Regulated Electric
Build Your Comparison
Side-by-side financial analysisStock Comparison
IMSR vs XOM vs CVX vs NNE vs SMR vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Industrial - Machinery
Renewable Utilities
Banks - Diversified
IMSR vs XOM vs CVX vs NNE vs SMR vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Regulated Electric | Oil & Gas Integrated | Oil & Gas Integrated | Industrial - Machinery | Renewable Utilities | Banks - Diversified |
| Market Cap | $625M | $597.52B | $359.97B | $1.04B | $1.43B | $892.31B |
| Revenue (TTM) | $0.00 | $323.90B | $184.43B | $0.00 | $19M | $280.33B |
| Net Income (TTM) | $-46M | $28.84B | $12.30B | $-31M | $-386M | $57.05B |
| Gross Margin | — | 21.7% | 30.4% | — | 22.4% | 60.0% |
| Operating Margin | — | 10.5% | 9.0% | — | -38.1% | 25.9% |
| Forward P/E | — | 12.9x | 12.6x | — | — | 14.3x |
| Total Debt | $2M | $43.54B | $46.74B | $3M | $0.00 | $942.38B |
| Cash & Equiv. | $97M | $10.68B | $6.47B | $203M | $836M | $343.34B |
IMSR vs XOM vs CVX vs NNE vs SMR vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 24 | Jun 26 | Return |
|---|---|---|---|
| Exxon Mobil Corpora… (XOM) | 100 | 120.2 | +20.2% |
| Chevron Corporation (CVX) | 100 | 111.2 | +11.2% |
| Nano Nuclear Energy… (NNE) | 100 | 335.7 | +235.7% |
| NuScale Power Corpo… (SMR) | 100 | 121.9 | +21.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 157.6 | +57.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IMSR vs XOM vs CVX vs NNE vs SMR vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 6 stocks, IMSR doesn't own a clear edge in any measured category.
XOM has the current edge in this matchup, primarily because of its strength in momentum and efficiency.
- +29.0% vs SMR's -74.9%
- 6.4% ROA vs SMR's -38.1%, ROIC 8.6% vs -314.7%
CVX is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 38 yrs, beta -0.31, yield 3.8%
- Better valuation composite
- 3.8% yield, 38-year raise streak, vs XOM's 2.8%, (3 stocks pay no dividend)
NNE is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 383.2% 10Y total return vs JPM's 475.6%
- Lower volatility, beta 3.93, Low D/E 1.3%, current ratio 53.48x
- Beta 3.93, current ratio 53.48x
- 3.4% revenue growth vs IMSR's -100.0%
SMR doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
JPM ranks third and is worth considering specifically for growth exposure.
- Rev growth 3.3%, EPS growth 1.5%
- 20.4% margin vs SMR's -20.7%
- Beta 0.94 vs IMSR's 4.60
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.4% revenue growth vs IMSR's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.4% margin vs SMR's -20.7% | |
| Stability / Safety | Beta 0.94 vs IMSR's 4.60 | |
| Dividends | 3.8% yield, 38-year raise streak, vs XOM's 2.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +29.0% vs SMR's -74.9% | |
| Efficiency (ROA) | 6.4% ROA vs SMR's -38.1%, ROIC 8.6% vs -314.7% |
IMSR vs XOM vs CVX vs NNE vs SMR vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
IMSR vs XOM vs CVX vs NNE vs SMR vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
XOM leads in 2 of 6 categories
JPM leads 1 • NNE leads 1 • IMSR leads 0 • CVX leads 0 • SMR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM and NNE operate at a comparable scale, with $323.9B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to SMR's -20.7%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $323.9B | $184.4B | $0 | $19M | $280.3B |
| EBITDAEarnings before interest/tax | -$38M | $59.9B | $37.1B | -$44M | -$711M | $81.4B |
| Net IncomeAfter-tax profit | -$46M | $28.8B | $12.3B | -$31M | -$386M | $57.0B |
| Free Cash FlowCash after capex | -$242M | $23.6B | $16.2B | -$38M | -$1.4B | $100.9B |
| Gross MarginGross profit ÷ Revenue | — | +21.7% | +30.4% | — | +22.4% | +60.0% |
| Operating MarginEBIT ÷ Revenue | — | +10.5% | +9.0% | — | -38.1% | +25.9% |
| Net MarginNet income ÷ Revenue | — | +8.9% | +6.7% | — | -20.7% | +20.4% |
| FCF MarginFCF ÷ Revenue | — | +7.3% | +8.8% | — | -74.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -1.3% | -5.3% | — | -95.8% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -60.3% | -11.0% | -24.5% | +68.4% | -145.5% | +16.0% |
Valuation Metrics
XOM leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 15.9x trailing earnings, JPM trades at a 41% valuation discount to CVX's 27.2x P/E. On an enterprise value basis, XOM's 10.5x EV/EBITDA is more attractive than JPM's 18.3x.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $625M | $597.5B | $360.0B | $1.0B | $1.4B | $892.3B |
| Enterprise ValueMkt cap + debt − cash | $530M | $630.4B | $400.2B | $842M | $589M | $1.49T |
| Trailing P/EPrice ÷ TTM EPS | -19.38x | 21.04x | 27.21x | -23.66x | -4.91x | 15.93x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.86x | 12.61x | — | — | 14.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | — | 10.52x | 10.78x | — | — | 18.32x |
| Price / SalesMarket cap ÷ Revenue | — | 1.84x | 1.95x | — | 45.28x | 3.19x |
| Price / BookPrice ÷ Book value/share | 1.83x | 2.28x | 1.74x | 4.27x | 1.57x | 2.46x |
| Price / FCFMarket cap ÷ FCF | — | 25.31x | 21.70x | — | — | 8.85x |
Profitability & Efficiency
XOM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-49 for SMR. IMSR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), IMSR scores 5/9 vs SMR's 0/9, reflecting solid financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -23.4% | +10.7% | +7.2% | -7.6% | -48.9% | +15.9% |
| ROA (TTM)Return on assets | -21.0% | +6.4% | +4.2% | -7.5% | -38.1% | +1.3% |
| ROICReturn on invested capital | -18.8% | +8.6% | +6.2% | -2.6% | -3.1% | +4.5% |
| ROCEReturn on capital employed | -16.7% | +8.9% | +6.6% | -35.8% | -87.8% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 5 | 4 | 0 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.16x | 0.24x | 0.01x | — | 2.60x |
| Net DebtTotal debt minus cash | -$95M | $32.9B | $40.3B | -$200M | -$836M | $599.0B |
| Cash & Equiv.Liquid assets | $97M | $10.7B | $6.5B | $203M | $836M | $343.3B |
| Total DebtShort + long-term debt | $2M | $43.5B | $46.7B | $3M | $0 | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | -5.45x | 69.44x | 17.22x | — | — | 0.74x |
Total Returns (Dividends Reinvested)
NNE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NNE five years ago would be worth $48,324 today (with dividends reinvested), compared to $3,332 for IMSR. Over the past 12 months, XOM leads with a +29.0% total return vs SMR's -74.9%. The 3-year compound annual growth rate (CAGR) favors NNE at 69.1% vs IMSR's -30.7% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.8% | +16.6% | +18.0% | -9.2% | -34.7% | -0.9% |
| 1-Year ReturnPast 12 months | -66.7% | +29.0% | +28.3% | -27.6% | -74.9% | +20.3% |
| 3-Year ReturnCumulative with dividends | -66.7% | +44.3% | +26.6% | +383.2% | +31.3% | +133.8% |
| 5-Year ReturnCumulative with dividends | -66.7% | +148.5% | +91.9% | +383.2% | +6.5% | +120.7% |
| 10-Year ReturnCumulative with dividends | -66.7% | +95.6% | +133.7% | +383.2% | +7.0% | +475.6% |
| CAGR (3Y)Annualised 3-year return | -30.7% | +13.0% | +8.2% | +69.1% | +9.5% | +32.7% |
Risk & Volatility
Evenly matched — XOM and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.37 beta — it tends to amplify market swings less than IMSR's 4.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 94.7% from its 52-week high vs SMR's 18.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.60x | -0.37x | -0.31x | 3.93x | 4.06x | 0.94x |
| 52-Week HighHighest price in past year | $27.16 | $176.41 | $214.71 | $60.87 | $57.42 | $337.25 |
| 52-Week LowLowest price in past year | $5.33 | $105.53 | $142.40 | $18.95 | $8.85 | $266.85 |
| % of 52W HighCurrent price vs 52-week peak | +27.8% | +79.9% | +84.0% | +41.2% | +18.5% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 43.3 | 48.7 | 44.2 | 41.1 | 65.0 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 13.7M | 8.1M | 2.6M | 32.3M | 7.0M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: XOM as "Hold", CVX as "Buy", NNE as "Buy", SMR as "Buy", JPM as "Buy". Consensus price targets imply 99.4% upside for NNE (target: $50) vs 6.4% for JPM (target: $340). For income investors, CVX offers the higher dividend yield at 3.81% vs JPM's 1.86%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $13.50 | $170.08 | $200.13 | $50.00 | $16.17 | $339.75 |
| # AnalystsCovering analysts | — | 55 | 53 | 3 | 16 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +2.8% | +3.8% | — | — | +1.9% |
| Dividend StreakConsecutive years of raises | — | 43 | 38 | — | — | 15 |
| Dividend / ShareAnnual DPS | — | $4.00 | $6.87 | — | — | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.4% | +3.3% | 0.0% | 0.0% | +3.9% |
XOM leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). JPM leads in 1 (Income & Cash Flow). 2 tied.
IMSR vs XOM vs CVX vs NNE vs SMR vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IMSR or XOM or CVX or NNE or SMR or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -100. 0% for Terrestrial Energy Inc. (IMSR). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 9x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate Chevron Corporation (CVX) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IMSR or XOM or CVX or NNE or SMR or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 9x versus Chevron Corporation at 27. 2x. On forward P/E, Chevron Corporation is actually cheaper at 12. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IMSR or XOM or CVX or NNE or SMR or JPM?
Over the past 5 years, Nano Nuclear Energy Inc (NNE) delivered a total return of +383.
2%, compared to -66. 7% for Terrestrial Energy Inc. (IMSR). Over 10 years, the gap is even starker: JPM returned +475. 6% versus IMSR's -66. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IMSR or XOM or CVX or NNE or SMR or JPM?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
37β versus Terrestrial Energy Inc. 's 4. 60β — meaning IMSR is approximately -1333% more volatile than XOM relative to the S&P 500. On balance sheet safety, Terrestrial Energy Inc. (IMSR) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — IMSR or XOM or CVX or NNE or SMR or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -100. 0% for Terrestrial Energy Inc. (IMSR). On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co. grew EPS 1. 5% year-over-year, compared to -200. 0% for Terrestrial Energy Inc.. Over a 3-year CAGR, SMR leads at 38. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IMSR or XOM or CVX or NNE or SMR or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -1130. 3% for NuScale Power Corporation — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -21. 9% for SMR. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IMSR or XOM or CVX or NNE or SMR or JPM more undervalued right now?
On forward earnings alone, Chevron Corporation (CVX) trades at 12.
6x forward P/E versus 14. 3x for JPMorgan Chase & Co. — 1. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NNE: 99. 4% to $50. 00.
08Which pays a better dividend — IMSR or XOM or CVX or NNE or SMR or JPM?
In this comparison, CVX (3.
8% yield), XOM (2. 8% yield), JPM (1. 9% yield) pay a dividend. IMSR, NNE, SMR do not pay a meaningful dividend and should not be held primarily for income.
09Is IMSR or XOM or CVX or NNE or SMR or JPM better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
37), 2. 8% yield). Terrestrial Energy Inc. (IMSR) carries a higher beta of 4. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +95. 6%, IMSR: -66. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IMSR and XOM and CVX and NNE and SMR and JPM?
These companies operate in different sectors (IMSR (Energy) and XOM (Energy) and CVX (Energy) and NNE (Industrials) and SMR (Utilities) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IMSR is a small-cap quality compounder stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; NNE is a small-cap quality compounder stock; SMR is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. XOM, CVX, JPM pay a dividend while IMSR, NNE, SMR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.